Virtual vs. Reality: External Validation of COVID-19 Classifiers using XCAT Phantoms for Chest Computed Tomography
Not on the map. Why?
Abstract (arXiv)
Research studies of artificial intelligence models in medical imaging have been hampered by poor generalization. This problem has been especially concerning over the last year with numerous applications of deep learning for COVID-19 diagnosis. Virtual imaging trials (VITs) could provide a solution for objective evaluation of these models. In this work utilizing the VITs, we created the CVIT-COVID dataset including 180 virtually imaged computed tomography (CT) images from simulated COVID-19 and normal phantom models under different COVID-19 morphology and imaging properties. We evaluated the performance of an open-source, deep-learning model from the University of Waterloo trained with multi-institutional data and an in-house model trained with the open clinical dataset called MosMed. We further validated the model's performance against open clinical data of 305 CT images to understand virtual vs. real clinical data performance. The open-source model was published with nearly perfect performance on the original Waterloo dataset but showed a consistent performance drop in external testing on another clinical dataset (AUC=0.77) and our simulated CVIT-COVID dataset (AUC=0.55). The in-house model achieved an AUC of 0.87 while testing on the internal test set (MosMed test set). However, performance dropped to an AUC of 0.65 and 0.69 when evaluated on clinical and our simulated CVIT-COVID dataset. The VIT framework offered control over imaging conditions, allowing us to show there was no change in performance as CT exposure was changed from 28.5 to 57 mAs. The VIT framework also provided voxel-level ground truth, revealing that performance of in-house model was much higher at AUC=0.87 for diffuse COVID-19 infection size >2.65% lung volume versus AUC=0.52 for focal disease with <2.65% volume. The virtual imaging framework enabled these uniquely rigorous analyses of model performance.
Key facts. Cited by 3 papers in the map (data through 7 Oct 2026). Builds on 8 of its 21 references that are in the map. First posted on arXiv 7 Mar 2022.
Builds on
8 of 21 references.
References · 8
- 2020COVID-Net: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest X-Ray Imagescited by 264
- 2020Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scanscited by 158
- 2020MosMedData: Chest CT Scans With COVID-19 Related Findings Datasetcited by 103
- 2020COVIDNet-CT: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases from Chest CT Imagescited by 39
- 2020Classification of Multiple Diseases on Body CT Scans using Weakly Supervised Deep Learningcited by 13
- 2020COVID-CT-MD: COVID-19 Computed Tomography (CT) Scan Dataset Applicable in Machine Learning and Deep Learningcited by 10
- 2020iPhantom: a framework for automated creation of individualized computational phantoms and its application to CT organ dosimetrycited by 5
- 2022Co-occurring Diseases Heavily Influence the Performance of Weakly Supervised Learning Models for Classification of Chest CTcited by 2
Built on by
Citing papers per year: 2023: 1; 2024: 1; 2025: 1.
3 papers.
- 2023The Utility of the Virtual Imaging Trials Methodology for Objective Characterization of AI Systems and Training Datacited by 4
- 2024INSIGHT: Explainable Weakly-Supervised Medical Image Analysiscited by 1
- 2025Virtual Patients, Real Gains: Digital Twin-Based Simulated CT for Multitask Lung Nodule Analysiscited by 1
- 2025Virtual Patients, Real Gains: Digital Twin-Based Simulated CT for Multitask Lung Nodule Analysis28 Feb 2025
- 2024INSIGHT: Explainable Weakly-Supervised Medical Image Analysis2 Dec 2024
- 2023The Utility of the Virtual Imaging Trials Methodology for Objective Characterization of AI Systems and Training Data17 Aug 2023